(1)
Immunological and Clinical Aspects Determining the Risk of Recurrence in Patients With Luminal Subtype of Breast Cancer Stages I–III. Вопр. онкол. 2025, 71 (3), OF-2271. https://doi.org/10.37469/0507-3758-2025-71-3-OF-2271.